Quick Answer
Can-Fite BioPharma Ltd. reported Total Assets of $9.51 million for the year ending 2025.
- Can-Fite BioPharma Ltd. showed an increase of +4.3% in Total Assets from 2024 to 2025.
- This data is from Can-Fite BioPharma Ltd.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 9 years of available data (2017 to 2025), Can-Fite BioPharma Ltd.'s Total Assets has grown by 25.0%.
- Historical annual values: Fiscal year 2025: $9.51 million | Fiscal year 2024: $9.12 million | Fiscal year 2023: $9.99 million | Fiscal year 2022: $9.28 million | Fiscal year 2021: $20.25 million | Fiscal year 2020: $9.52 million | Fiscal year 2019: $8.17 million | Fiscal year 2018: $7.95 million | Fiscal year 2017: $7.61 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: